Aurobindo gets Australian nod for cholesterol pills
11 May 2009
Drug maker Aurobindo Pharma today said it had received Australian regulatory approval for registration of Simvastatin tablets, used in the treatment of high cholesterol.
In a filing to the Bombay Stock Exchange, the company said its wholly-owned subsidiary Aurobindo Pharma Australia Pty Ltd has received approval from Australia's Therapeutic Goods Administration for the registration.
Simvastatin is a common prescription medication used in the treatment of high cholesterol. The drug also decreases the chance of developing cardiovascular diseases. The tablets are in the strength of 5, 10, 20, 40 and 80 mg.
Earlier in March, the company had received two TGA approvals for its Lisinopril and Sertraline tablets. This is the third approval received by the company from TGA, Australia, it said.
